A company with world class scientist...leadership...partnerships with billions in milestones, late entries for 3 trial updates at annual ASCO, a mean target from a handful of analyst at $45.00 is trading at $21/share and has been slaughtered for months now...well makes sense to me.
Notwithstanding the real promise here, let's face it, virtually all high beta mo-mo names have been in the penalty box for the last two months and OMED is being carried along with the so-called risk off tide. I don't see where the story has changed but until the speculative appetite returns it will continue to wallow, especially with a big short. Let's hope ASCO provides a spark. GL to Ls.
#$%$ is going on with this stock??? NASDAQ up 1% today! This is just insane, 30% down on my investment, worse than a penny stock! NO words of encouragement from OMED Management........ This has to be shorting and needs to be looked into.